D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+4.33%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$82B
AUM Growth
+$3.66B
Cap. Flow
-$9B
Cap. Flow %
-10.97%
Top 10 Hldgs %
11.9%
Holding
4,466
New
785
Increased
1,428
Reduced
1,270
Closed
449

Sector Composition

1 Technology 19.98%
2 Consumer Discretionary 13.5%
3 Financials 10.53%
4 Healthcare 10.18%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MCRB icon
3251
Seres Therapeutics
MCRB
$138M
$243K ﹤0.01%
1,457
+648
+80% +$108K
PANA
3252
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$243K ﹤0.01%
25,008
+9,812
+65% +$95.3K
AIP icon
3253
Arteris
AIP
$372M
$242K ﹤0.01%
+11,448
New +$242K
ALB icon
3254
Albemarle
ALB
$8.93B
$242K ﹤0.01%
1,036
-400
-28% -$93.4K
TRC icon
3255
Tejon Ranch
TRC
$452M
$241K ﹤0.01%
+12,622
New +$241K
BFS
3256
Saul Centers
BFS
$784M
$241K ﹤0.01%
4,550
-1,793
-28% -$95K
SONY icon
3257
Sony
SONY
$175B
$241K ﹤0.01%
9,535
-100,270
-91% -$2.53M
STOK icon
3258
Stoke Therapeutics
STOK
$1.27B
$241K ﹤0.01%
+10,065
New +$241K
PDSB icon
3259
PDS Biotechnology
PDSB
$55.5M
$240K ﹤0.01%
+29,605
New +$240K
DH icon
3260
Definitive Healthcare
DH
$431M
$238K ﹤0.01%
+8,697
New +$238K
IPSC icon
3261
Century Therapeutics
IPSC
$42.8M
$238K ﹤0.01%
15,037
-5,819
-28% -$92.1K
VIA
3262
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$237K ﹤0.01%
4,144
+1,782
+75% +$102K
SUNL
3263
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$237K ﹤0.01%
+2,478
New +$237K
KBAL
3264
DELISTED
Kimball International
KBAL
$236K ﹤0.01%
23,024
-9,883
-30% -$101K
CYCN icon
3265
Cyclerion Therapeutics
CYCN
$7.85M
$235K ﹤0.01%
6,830
-6,798
-50% -$234K
XAGE
3266
Longevity Health Holdings, Inc. Common Stock
XAGE
$4.13M
$235K ﹤0.01%
+811
New +$235K
PFC
3267
DELISTED
Premier Financial Corp. Common Stock
PFC
$234K ﹤0.01%
+7,566
New +$234K
MITT
3268
AG Mortgage Investment Trust
MITT
$245M
$233K ﹤0.01%
22,685
-20,572
-48% -$211K
CVIIW
3269
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$233K ﹤0.01%
232,985
BNS icon
3270
Scotiabank
BNS
$78.8B
$232K ﹤0.01%
3,230
-306,794
-99% -$22M
BRX icon
3271
Brixmor Property Group
BRX
$8.58B
$232K ﹤0.01%
9,115
-93,841
-91% -$2.39M
NAGE
3272
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
$232K ﹤0.01%
62,042
+15,226
+33% +$56.9K
CSWC icon
3273
Capital Southwest
CSWC
$1.27B
$231K ﹤0.01%
+9,144
New +$231K
EMN icon
3274
Eastman Chemical
EMN
$7.69B
$231K ﹤0.01%
1,911
-140,841
-99% -$17M
MNMD icon
3275
MindMed
MNMD
$720M
$231K ﹤0.01%
11,147
-221
-2% -$4.58K